📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Chemical informatics uncovers a new role for moexipril as a novel inhibitor of cAMP phosphodiesterase-4 (PDE4). (2013)

First Author: Cameron RT

Attributed to: cAMP phosphodiesterase-4: signalling complexes, regulation and potential therapeutic targets. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.bcp.2013.02.026

PubMed Identifier: 23473803

Publication URI: http://europepmc.org/abstract/MED/23473803

Type: Journal Article/Review

Volume: 85

Parent Publication: Biochemical pharmacology

Issue: 9

ISSN: 0006-2952